Cipla Quality Chemical Industries Limited (CiplaQCIL) is a state-of-the-art pharmaceutical manufacturing company located in Kampala, Uganda. The company manufactures Anti-retroviral (ARVs), Artemisinin-based Combination Therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, Malaria and Hepatitis.

Latest Updates

August 15, 2018

CiplaQCIL Prospectus

This Prospectus provides detailed information about the Company and the Offer. Potential investors in respect of the Offer Shares are advised to read this document carefully […]
August 3, 2018

CiplaQCIL announcement of Intention for initial public offering and listing on the use

Uganda, Kampala [2 August 2018] – As part of its growth strategy, the board of Cipla Quality Chemical Industries Ltd (CiplaQCIL or the Company) has been […]
October 17, 2017

CiplaQCIL Marks 10 year anniversary with blood donation drive

This year, CiplaQCIL marked 10 years of providing access to quality affordable medicines. CiplaQCIL marked this momentous occasion with a blood donation drive at the factory […]